Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary(®)): Results of a Nationwide Dose Conversion Survey

BACKGROUND: The introduction of carbidopa-levodopa extended-release (CD-LD ER) capsules (Rytary®) did not go as smoothly as expected, largely due to difficulty around dose conversion from available immediate-release (IR) levodopa (LD) formulations. The dose conversion table in the CD-LD ER prescribi...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Parkinsons Dis
Главные авторы: Hauser, Robert A., Banisadr, Ghazal, Vuong, Kara, Freilich, David, Fisher, Stanley, D'Souza, Richard
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914099/
https://ncbi.nlm.nih.gov/pubmed/33688424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6638088
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы